company

ProPharma Group

as of 2026-07-01
at a glance
1 trials sponsored · 3 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

3 assets

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
drug
BXCL501 60 Micrograms
small molecule
drug
BXCL501 80 Micrograms
small molecule
drug